Clinical trial
Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or…
NCT00239616 · American Regent, Inc., Industry · Completed
Key facts
| NCT number | NCT00239616 |
|---|---|
| Title | Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin |
| Official title | Open-label Multicenter, Pharmacokinetic Study of a Single Dose of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin |
| Lead sponsor | American Regent, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Iron Sucrose injection |
| Enrollment | 10 |
| Start date | Jun 5, 2002 |
| Primary completion | Sep 15, 2003 |
| Completion | Sep 15, 2003 |
| First posted | Oct 17, 2005 |
| Last update posted | May 18, 2025 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: